menu
Showcases Stock ranks

TherapeuticsMD Inc. (TXMD) (TXMD)
1.08 -0.21 (-16.28%) 03-27 16:00
Open: 1.19 Pre. Close: 1.29
High: 1.2001 Low: 1.04
Volume: 4,212,094 Market Cap: 293M
TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 1.201 - 1.207 1.207 - 1.212
Low: 1.027 - 1.033 1.033 - 1.037
Close: 1.071 - 1.081 1.081 - 1.088
Stock Technical Analysis
Overall:     
Target: Six months: 1.88
One year: 2.39
Support: Support1: 0.90
Support2: 0.75
Resistance: Resistance1: 1.61
Resistance2: 2.05
Pivot: 1.26
Moving Averages: MA(5): 1.16
MA(20): 1.38
MA(100): 2.22
MA(250): 2.83
MACD: MACD(12,26): -0.24
Signal(12,26,9): -0.25
%K %D: %K(14,3): 34.18
%D(3): 31.20
RSI: RSI(14): 35.52
52-Week: High: 5.04
Low: 0.9
Change(%): -77.6
Average Vol(K): 3-Month: 413050
10-Days: 510890
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

TXMD has closed above bottom band by 27.4%. Bollinger Bands are 26% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
2020-03-27
The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance
Here's a roundup of top developments in the biotech space over the … Full story available on Benzinga.com

2020-03-26
TherapeuticsMD suspends guidance due to Covid-19
TherapeuticsMD (NASDAQ:TXMD) announces cost-reduction initiatives amid the uncertainties of the COVID-19 pandemic. It has also "suspended" its 2020 guidanc

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 271.18
Shares Float (M) 237.49
% Held by Insiders 12.68
% Held by Institutions 71.90
Shares Short (K) 90620
Shares Short Prior Month (K) 90930
Stock Financials
EPS -0.715
Book Value (p.s.) 0.030
PEG Ratio
Profit Margin
Operating Margin -304.56
Return on Assets (ttm) -39.5
Return on Equity (ttm) -330.1
Qtrly Rev. Growth 212.4
Gross Profit (p.s.) 0.160
Sales Per Share 0.183
EBITDA (p.s.) -0.552
Qtrly Earnings Growth
Operating Cash Flow (M) -165.70
Levered Free Cash Flow (M) -128.31
Stock Valuation
P/E -1.51
P/E Growth Ratio -0.16
P/BV 36.00
P/S
P/CF -1.77
Dividend Yield
Dividends & Splits
Dividend
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2011-10-02
Last Split Ratio 0.01

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator